May 27, 2021
Via: MedPageTodayFDA authorized another monoclonal antibody, sotrovimab, for emergency use in COVID-19 patients at high risk of severe disease, the agency announced on Wednesday. Sotrovimab received emergency use authorization (EUA) for patients 12 years and older with mild to moderate COVID-19, […]